Trial
NCT00840463
Safety and Efficacy Trial to Treat Diastolic Heart Failure Using Ambrisentan
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Texas Southwestern Medical Center
Collaborators
Gilead Sciences
Condition
Pulmonary Hypertension
Intervention
Ambrisentan
Why stopped
Poor enrolment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-19